While there haven't been any firm estimates on the off-label use of devices treating atrial fibrillation (AF), the fact remains that this is a strong concern for the FDA especially since in the past there haven't been any devices specifically approved for this indication. That's changed recently, as AtriCure (West Chester, Ohio) reported that it has gained FDA approval for its Synergy ablation system for the treatment of AF.